Activating Compound | Comment | Organism | Structure |
---|---|---|---|
additional information | Rho kinase is an important downstream effector of RhoA GTPases | Homo sapiens |
Inhibitors | Comment | Organism | Structure |
---|---|---|---|
atorvastatin | marketed as Lipitor, i.e. [R-(R*,R*)]-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid, inhibits RhoA activity by reducing Rho geranylgeranylation | Homo sapiens | |
CCG-1423 | - |
Homo sapiens | |
CCG-977 | - |
Homo sapiens | |
cerivastatin | marketed as Baycol/Lipobay, i.e. (E,3R,5S)-7-[4-(4-fluorophenyl)-5-(methoxymethyl)-2,6-dipropan-2-yl-pyridin-3-yl]-3,5-dihydroxy-hept-6-enoic acid, RhoA inhibitor | Homo sapiens | |
lovastatin | marketed as Mevacor, i.e. 8-[2-(4-hydroxy-6-oxo-oxan-2-yl)ethyl]-3,7-dimethyl-1,2,3,7,8,8a-[hexahydronaphthalen-1-yl]2-methylbutanoate | Homo sapiens | |
NSC23766 | not very potent inhibitor of Rac1 and Cdc42 | Homo sapiens | |
simvastatin | marketed as Zocor, i.e. [(1S,3R,7R,8S,8aR)-8-[2-[(2R,4R)-4-hydroxy-6-oxo-oxan-2-yl]ethyl]3.7-dimethyl]-1,2,3,7,8,8a-[hexahydronaphthalen-1-yl]2,2-dimethylbutanoate | Homo sapiens |
Localization | Comment | Organism | GeneOntology No. | Textmining |
---|---|---|---|---|
membrane | - |
Homo sapiens | 16020 | - |
Organism | UniProt | Comment | Textmining |
---|---|---|---|
Homo sapiens | - |
- |
- |
Source Tissue | Comment | Organism | Textmining |
---|---|---|---|
erythroleukemia cell | - |
Homo sapiens | - |
HT-29 cell | - |
Homo sapiens | - |
MDA-MB-231 cell | - |
Homo sapiens | - |
PC-3 cell | - |
Homo sapiens | - |
Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|
GTP + H2O | - |
Homo sapiens | GDP + phosphate | - |
? |
Synonyms | Comment | Organism |
---|---|---|
Cdc42 | - |
Homo sapiens |
Rac1 | - |
Homo sapiens |
Rho GTPase | - |
Homo sapiens |
RhoA | - |
Homo sapiens |